Compare FEIM & AGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FEIM | AGL |
|---|---|---|
| Founded | 1961 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Managed Health Care |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 494.3M | 422.9M |
| IPO Year | 1994 | 2021 |
| Metric | FEIM | AGL |
|---|---|---|
| Price | $46.15 | $0.60 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 14 |
| Target Price | ★ $42.50 | $2.66 |
| AVG Volume (30 Days) | 127.8K | ★ 6.9M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 316.95 | N/A |
| EPS | ★ 0.25 | N/A |
| Revenue | $69,811,000.00 | ★ $5,932,576,000.00 |
| Revenue This Year | $5.52 | N/A |
| Revenue Next Year | $17.07 | $7.17 |
| P/E Ratio | $204.00 | ★ N/A |
| Revenue Growth | ★ 26.30 | N/A |
| 52 Week Low | $14.41 | $0.34 |
| 52 Week High | $61.47 | $6.08 |
| Indicator | FEIM | AGL |
|---|---|---|
| Relative Strength Index (RSI) | 42.07 | 49.56 |
| Support Level | $45.65 | $0.51 |
| Resistance Level | $59.91 | $0.73 |
| Average True Range (ATR) | 4.97 | 0.08 |
| MACD | -0.03 | 0.02 |
| Stochastic Oscillator | 10.60 | 60.69 |
Frequency Electronics Inc is engaged in the design, development, and manufacture of high-precision timing, and frequency control products for space, air, sea, and terrestrial applications. The company has FEI-NY and FEI-Zyfer reportable segments. It derives the majority of its revenues from the FEI-NY segment. FEI-NY segment operations consist principally of precision time and frequency control products used in three principal markets namely communication satellites (both commercial and U.S. Government-funded); terrestrial cellular telephone or other ground-based telecommunication stations; and other components and systems for the U.S. military.
Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.